Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making

Key Result

Post-transplant cyclophosphamide is associated with early cardiac complications in patients undergoing allogeneic stem cell transplantation.

Key Points

• This study aims to evaluate the cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplant patients.
• Collaborative assessment involving registered nurses and advanced practice providers
• Evaluation of cardiac function following post-transplant cyclophosphamide administration
• Decision-making protocols implemented for monitoring cardiac health
• Identified instances of early cardiac complications linked to post-transplant cyclophosphamide therapy
• Recommendations for regular cardiac monitoring to mitigate risks
• Improved decision-making frameworks for managing cardiac health in this patient population